Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Daniel I. G. Cubero"'
Autor:
Daniel I. G. Cubero, Auro del Giglio
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 5 (2013)
Externí odkaz:
https://doaj.org/article/5e578e3b19d44926a7eb084c36374ca6
Autor:
Cora N, Sternberg, Karim, Fizazi, Fred, Saad, Neal D, Shore, Ugo, De Giorgi, David F, Penson, Ubirajara, Ferreira, Eleni, Efstathiou, Katarzyna, Madziarska, Michael P, Kolinsky, Daniel I G, Cubero, Bettina, Noerby, Fabian, Zohren, Xun, Lin, Katharina, Modelska, Jennifer, Sugg, Joyce, Steinberg, Maha, Hussain, R, Waterhouse
Publikováno v:
Sternberg, C N, Fizazi, K, Saad, F, Shore, N D, de Giorgi, U, Penson, D F, Ferreira, U, Efstathiou, E, Madziarska, K, Kolinsky, M P, Cubero, D I G, Noerby, B, Zohren, F, Lin, X, Modelska, K, Sugg, J, Steinberg, J, Hussain, M & The PROSPER Investigators 2020, ' Enzalutamide and survival in nonmetastatic, castration-resistant prostate cancer ', New England Journal of Medicine, vol. 382, no. 23, pp. 2197-2206 . https://doi.org/10.1056/NEJMoa2003892
New England Journal of Medicine, 382(23), 2197-2206. MASSACHUSETTS MEDICAL SOC
New England Journal of Medicine, 382(23), 2197-2206. MASSACHUSETTS MEDICAL SOC
Preliminary trial results showed that enzalutamide significantly improved metastasis-free survival among men who had nonmetastatic, castration-resistant prostate cancer and rapidly increasing prostate-specific antigen (PSA) levels while taking androg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ada3068f332332d3148bedbc332995e5
https://research.rug.nl/en/publications/55cc0758-3a20-4830-a0d2-94595129fd5f
https://research.rug.nl/en/publications/55cc0758-3a20-4830-a0d2-94595129fd5f
Autor:
Daniel I G Cubero, Beatrice Martinez Zugaib Abdalla, Jean Schoueri, Fabio Iazetti Lopes, Karine Corcione Turke, Jose Guzman, Auro Del Giglio, Carlos D’Apparecida Santos Machado Filho, Vanessa Salzano, Dolores Gonzalez Fabra
Publikováno v:
Drugs in Context, Vol 7, Pp 1-11 (2018)
Background: Currently, molecularly targeted drugs are part of the therapeutic arsenal for the treatment of many neoplasms and are responsible for improvements in the quality of life and survival of patients. Although they act on proteins and componen
Externí odkaz:
https://doaj.org/article/16844e613a014b0d82429aac42b4d28d